Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00882778 · ClinicalTrials.gov registry record
PROPACT: Retrospective Prophylaxis Patient Case Collection
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 86
- Enrollment target
NCT00882778 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 86 participants.
The verdict
NCT00882778 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
This study is conducted in Europe and North and South America. The primary aim of this observational study is to evaluate the frequency and pattern of bleeding episodes in haemophilia patients receiving preventative treatment with activated recombinant human factor VII. The secondary aim is to evaluate which patients are selected for this treatment, the dose and dose intervals used, and the safety of activated recombinant human factor VII when used as prevention. The study also aims to increase understanding of the unmet medical need and clinical relevance of preventative treatment in haemophilia patients.
Interventions
- DRUG eptacog alfa (activated)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00882778
The ClinicalTrials.gov registry entry for NCT00882778 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eptacog alfa (activated) is the first listed.
NCT00882778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00882778 about?
NCT00882778 is a clinical study titled "PROPACT: Retrospective Prophylaxis Patient Case Collection". This study is conducted in Europe and North and South America. The primary aim of this observational study is to evaluate the frequency and pattern of bleeding episodes in haemophilia patients receiving preventative treatment with activated recombinant human factor VII. The secondary aim is to evalu...
What is the current status of trial NCT00882778?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2009-04. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00882778?
The interventions under investigation include: eptacog alfa (activated) (DRUG).
Who is sponsoring clinical trial NCT00882778?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.